Evidence-based guides on GLP-1 medications, the conditions they treat, and the questions every Indian patient asks before starting. Written by the Kaivo medical team, reviewed by our AIIMS-trained doctors.
Why insulin resistance drives PCOS weight gain — and how GLP-1s address the root cause.
Read the guideHow GLP-1s changed T2D treatment. HbA1c, cardiovascular and kidney outcomes — and what makes Indian diabetes different.
Read the guideHypothyroidism rarely causes more than 2–5 kg of weight gain. The honest answer on when GLP-1s help.
Read the guideOzempic, Wegovy, Rybelsus — same molecule, different brands. Trials, side effects, dosing, week by week.
Read the guideThe dual GIP/GLP-1 agonist with ~21% trial weight loss. SURMOUNT-1, SURPASS-2, SUMMIT, OSA data.
Read the guideMounjaro is tirzepatide. How it compares to Wegovy, Ozempic, generic semaglutide and Rybelsus.
Read the guideWhat Ozempic, Wegovy, Mounjaro and generic semaglutide cost per month in 2026 — after the price cuts.
See the pricesHit 90–100g a day without meat — gram math on dal, paneer, whey, soya and besan chilla, plus a Jain meal plan.
Read the post25–40% of every kilo lost can be muscle. The protein, training and creatine playbook — and why Indians are highest-risk.
Read the postEvery baseline and monitoring marker in plain language — and why B12 and vitamin D matter most in India.
Read the postExact fridge windows, flight rules, a power-cut protocol, and cooling gear with prices — keep your pen from spoiling.
Read the postThe honest regain data, the lowest maintenance dose that holds ~70%, and the India cost math in rupees.
Read the postThe five causes of a tirzepatide plateau — starter dose, calorie creep, muscle loss, water, fake pens — and a doctor-led decision tree.
Read the postEndocrinologist, GP, or online — who can legally prescribe it, what it costs, what tests to expect, and what to do if a doctor refuses.
Read the postAn hour-by-hour walkthrough of day one through day seven — what's anxiety, what's the drug, and exactly when to call.
Read the postA survival guide for Indian diets — 30-second fixes, the trigger-food calendar, and which OTC products actually help.
Read the postMounjaro is India's top-selling drug by value — so why is it still treated as a moral scandal? The science, the conflicts, the gendered cost.
Read the post2.5 to 15 mg, step by step — weight loss range, side effects, cost at each rung, and where most patients should actually stop.
Read the postPharmacy-by-pharmacy after the April 2026 Gurugram bust — Cipla-direct, the apps, red flags, cold-chain checklist.
Read the postSix visual checks, batch numbers flagged so far, Lilly India contacts, and the legal action sequence if you've been sold a counterfeit.
Read the postHow to switch without losing progress — dose equivalence, the 4-week plan, when not to switch, and how to pick the right Indian generic.
Read the post30 terms every new user in India should know — from "golden dose" and "food noise" to Schedule H and CDSCO batch numbers.
Read the postNausea, diarrhoea, vomiting — what's common, what's rare, what's a red flag, and what to actually do.
Read the postPlain-English on what semaglutide actually is, the three switches it flips in your body, and what to expect.
Read the postThe SURMOUNT-5 head-to-head, SURPASS-2, and a decision framework for Indian patients.
Read the postYes, since December 2025. What is legally available now, and what changed after the March 2026 patent expiry.
Read the postSTEP trial evidence, eligibility for Indian patients, side effects, and who it is right for.
Read the postTake the 2-minute test. See if Kaivo is right for you.